Table 1.
Antimicrobial susceptibility results for the clinical isolates described in this study
MIC (mg/L), S/R |
|||||||||
---|---|---|---|---|---|---|---|---|---|
Strain | CAZ/AVI | CAZ | FEP | CTX | ETP | IPM | MEM | TZP | GEN |
Kp-1-S | 2, S | >8, R | >8, R | >8, R | >8, R | >16, R | >16, R | >128, R | 4, S |
Kp-2-R | 32, R | >8, R | >8, R | >8, R | >8, R | 0.5, S | 2, S | >128, R | 4, S |
CAZ/AVI, ceftazidime/avibactam; CAZ, ceftazidime; FEP, cefepime; CTX, cefotaxime; ETP, ertapenem; IPM, imipenem; MEM, meropenem; TZP, piperacillin/tazobactam; GEN, gentamicin; S, susceptible; R, resistant.